Oxford Cannabinoid Technologies (OCTP) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free OCTP Stock Alerts GBX 0.16 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | americanbankingnews.comOxford Cannabinoid Technologies (LON:OCTP) Shares Down 66.6% May 8, 2024 | marketwatch.comOxford Cannabinoid to Delist from London Stock ExchangeMay 8, 2024 | msn.comA bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London marketsOctober 15, 2023 | wsj.comOxford Cannabinoid Technologies Holdings PLCOctober 12, 2023 | benzinga.comWeed In Europe: Medical Marijuana In Ukraine, Albania's Hemp, UK Cannabis Study Lacks DiversityOctober 10, 2023 | finance.yahoo.comOxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trialOctober 10, 2023 | proactiveinvestors.comOxford Cannabinoid readies for next stage as it safely navigates phase I stduyOctober 10, 2023 | proactiveinvestors.comOxford Cannabinoid readies for next stage as it safely navigates phase I studySeptember 25, 2023 | finance.yahoo.comOxford Cannabinoid Technologies reports no adverse events in OCT461201 trialSeptember 1, 2023 | finance.yahoo.comOxford Cannabinoid Technologies in a "comfortable position" ahead of Phase 1 results releaseAugust 31, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies hails defining year as...Oxford Cannabinoid Technologies hails defining year as clinical...July 28, 2023 | finance.yahoo.comOxford Cannabinoid Technologies "officially on the way" after first dosingJuly 27, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies takes pain drug into phase I; appoints leading pain expertJuly 24, 2023 | finance.yahoo.comOxford Cannabinoid Technologies announces "potential breakthrough" in field of oncologyJune 8, 2023 | proactiveinvestors.comOxford Cannabinoid appoints chief medical officerMay 18, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies reaches milestone with phase 1 trial approval for pain relief drugMay 17, 2023 | proactiveinvestors.comOxford Cannabinoid rise continues as first clincial trial gets startedApril 13, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies confirms CEO appointment, licence renewal and clinical progressApril 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEOApril 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies shares spike on CEO appointment and licence renewalMarch 1, 2023 | finance.yahoo.comOxford Cannabinoid Technologies Holdings Plc (OCTP.L)February 10, 2023 | uk.investing.comOxford Cannabinoid Technologies Holdings PLC (OCTP)January 25, 2023 | lse.co.ukOxford Cannabinoid interim loss nearly doubles as research costs surgeJanuary 24, 2023 | proactiveinvestors.comProactive's John Savin publishes fresh research note on Oxford Cannabinoid TechnologiesJanuary 23, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies with "lots to look forward to" after interimsJanuary 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "proceeding forward as planned" after review meetingJanuary 6, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "ready to go" after phase 1 trial submissionJanuary 5, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies hails 'milestone' as it submits Phase I trial application for lead programmeNovember 14, 2022 | proactiveinvestors.comOxford Cannabinoid Technologies nearly ready for new phase 1 trialNovember 14, 2022 | finance.yahoo.comData from pre-clinical study of OCT461201 shows positive results Get Oxford Cannabinoid Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OCTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. OCTP Media Mentions By Week OCTP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCTP News Sentiment▼-0.140.55▲Average Medical News Sentiment OCTP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCTP Articles This Week▼10▲OCTP Articles Average Week Get Oxford Cannabinoid Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OCTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Physiomics News ReNeuron Group News ValiRx News Evgen Pharma News Fusion Antibodies News IXICO News Roquefort Therapeutics News genedrive News IQ-AI News Surgical Innovations Group News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OCTP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Cannabinoid Technologies Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
